Programmed cell death (apoptosis) is mainly responsible for neuronal damage in neurodegenerative diseases. Thus, inhibition of apoptosis could represent an effective strategy in the prevention of these diseases. In this study, we aimed to compare the apoptotic responses of neurotoxins that are widely used to induce neuronal damage in cell culture studies and help to decide the most suitable experimental model for drug studies that target apoptosis. Cell viability analyses were performed by MTT assay following 1-methyl-4-phenylpyridinium (MPP + ), 6-hydroxydopamine (6-OHDA), rotenone and paraquat treatments at three different time points (12, 24, 48h). Pro-apoptotic (Bax, Bad, Bak), anti-apoptotic (Bcl-2, Bcl-xl) protein levels and total caspase-3 protein levels were determined by Western Blotting technique following treatments. As expected, all neurotoxins managed to trigger cell death and apoptotic pathway. On the other hand, each neurotoxin was found to enhance and/or reduce the levels of different proteins that are associated with apoptosis. Due to different responses of apoptosis related proteins to neurotoxins, it can be concluded that the determination of target proteins with a number of protein-binding assays prior to cell culture studies and then deciding an in vitro model are essential while screening newly synthesized drugs that target apoptosis.
INTRODUCTION
Parkinson's disease (PD) is one of the most common neurodegenerative disorder affecting 2% of the population over 65 years of age [1] . There are various mechanisms including free radical formation, oxidative/nitrosative stress, mitochondrial dysfunction, excitotoxicity, environmental and genetic factors that cause neurodegeneration. These factors lead to neuronal dysfunction, atrophy and finally apoptosis [2] . It is not easy to find an effective therapeutic approach for neurodegenerative diseases because of the complexity of processes. Nowadays, new potential drugs such as GSK3β inhibitors, cyclin dependent kinase inhibitors, c-JNK pathway inhibitors and apoptosis inhibitors are under investigation for clinical applications in the future [3] [4] [5] [6] [7] .
Apoptosis is a controlled and programmed cell death responsible for regulating homeostasis of multicellular organisms under physiological conditions [8] [9] [10] [11] . Apoptosis occurs via the intrinsic (mitochondrial) pathway, extrinsic (death receptor) pathway and endoplasmic reticulum (ER) pathway [12] . The mitochondrial pathway is mainly regulated by Bcl-2 (B-cell lymphoma 2) family proteins which consist of three sub-families namely anti-apoptotic sub-family (Bcl-xL (B-cell lymphoma-extra large) and Bcl-2), proapoptotic BH3 only proteins (Bid (BH3 interacting-domain death agonist) and Bad (Bcl-2 associated death promoter)) and sub-family including Bak (Bcl-2 homologous antagonist killer) and Bax (Bcl-2 associated x protein) [13] .
Environmental factors have been shown to contribute to the incidence of Parkinson's disease. Pesticides such as insecticide, herbicide, rodenticide, fungicide, fumigant exhibit a wide variety of chemical structures [14] . 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is the first known agent which induces Parkinsonian symptoms in animal models [15] . MPTP can cross the blood-brain barrier and converted into its toxic oxidized product, 1-methyl-4-phenylpyrdinium (MPP + ), inside the brain cells [16] . Paraquat (1,1'dimethyl-4,4'-bipyridinium dichloride) is a highly toxic quaternary nitrogenous herbicide. After absorption, paraquat accumulates in the lungs and kidneys and triggers acute toxicological effects regardless of the route of exposure. In contrast to MPP + , paraquat has been reported to be a weak inhibitor of complex I of the electron transport chain [17] . Rotenone is a broad-spectrum agricultural pesticide and a high-affinity specific complex I (NADH-dehydrogenase) inhibitor. It is highly hydrophobic and easily passes through biological membranes. Unlike MPTP, rotenone does not require a dopamine transporter (DAT) to reach the cytoplasm [17] . 6-hydroxydopamine (6-OHDA) is an other neurotoxin commonly used in animal models of PD increases the iron levels in the substantia nigra [18, 19] and interacts directly with the complexes I and IV of the mitochondrial respiratory chain, leading to respiratory inhibition and oxidative stress [20] .
Very few studies were reported to compare the biological and toxicological responses of neural and glial cells following widely used experimental toxins [21] [22] [23] [24] [25] . In this study, we aimed to compare four different neurotoxins in terms of apoptotic/anti-apoptotic protein alterations while triggering dopaminergic cell death. Our results may help to choose suitable experimental model while studying drug candidate molecules that target specific apoptosis-related proteins.
RESULTS

Neurotoxin treatments decreased survival and viability of cells
Selected neurotoxins (MPP + , rotenone, paraquat and 6-OHDA) are widely used toxins for inducing dopaminergic cell damage in in vitro studies. In this study, to confirm their toxicity, the cells were treated with MPP + , rotenone, paraquat and 6-OHDA individually at three different concentrations and three different time periods (12, 24, 48 hours) . As shown in Figure 1 , IC50 values for MPP + , rotenone, paraquat and 6-OHDA were found as 2.3 mM, 44.37 µM, 388.4 µM and 79.1 µM, respectively at 24h. 
Effect of MPP + , rotenone, paraquat, 6-OHDA on pro-apoptotic and anti-apoptotic protein levels
To evaluate the role of neurotoxins and compare their efficiencies, the effects of neurotoxins on expressions of pro-apoptotic (Bax, Bak and Bad) and anti-apoptotic (Bcl-2, Bcl-xl) proteins were determined. As expected, pro-apoptotic and anti-apoptotic protein levels altered following treatments.
As shown in Figure 2 , Bax protein levels were significantly increased following rotenone and paraquat treatments when compared to other groups (p<0.05). Among neurotoxins, rotenone was found to increase Bax levels at highest ratio at selected concentration (1,69-fold, p<0.0001). Similarly, Bak protein levels were significantly increased (1.04-fold) following paraquat (p <0.05). As it is shown in Fig. 2 , Bad protein levels were significantly increased when cells were treated by 6-OHDA (2.67-fold, p<0.05). Figure 3 showed the effect of four neurotoxins on anti-apoptotic Bcl-2 and Bcl-xl protein levels in cells. MPP + , rotenone and paraquat treatments significantly decreased Bcl-2 and Bcl-xl levels when compared to untreated cells (p <0.05). 1.17, 1.08, 1.12, 0.96-fold decreases in Bcl-2 levels were observed following MPP + , rotenone and paraquat treatments, respectively. In addition to these neurotoxins, 6-OHDA treatment significantly decreased Bcl-xl levels as well (6.25-fold). In this study, we assessed the effect of neurotoxins in the relative ratio of Bax/Bcl-2 proteins by Western Blot analysis. Meanwhile, selected neurotoxins were compared in terms of Bax/Bcl-2 ratio. As shown in Figure 4 , the densitometric analysis demonstrated that MPP + , rotenone and paraquat-treated cells had high Bax/Bcl-2 ratio as compared with untreated and 6-OHDA-treated cells (p<0.05). When neurotoxins were compared, rotenone was found to increase Bax/Bcl-2 ratio more efficiently (1.83-fold, p<0.05). 
Effect of MPP + , rotenone, paraquat, 6-OHDA on caspase-3 protein levels
The alterations in caspase-3 protein levels following the administration of four neurotoxins in SH-SY5Y cells were evaluated ( Figure 5 ). Although insignificant, both MPP + and 6-OHDA decreased total caspase-3 levels at 24h exposure (p>0.05). On the other hand, other neurotoxins did not change caspase-3 levels. 
DISCUSSION
The compounds with structural diversity including MPTP (active form MPP + ), rotenone, paraquat and 6-OHDA are used to generate the Parkinson's Disease experimental models. In this study, we aimed to compare these four in vitro experimental models in terms of apoptotic responses. At first, cellular viability following different concentrations of neurotoxins at three different time points were evaluated. Similar to previous findings, all selected compounds achieved to decrease cell viability nearly 50% at 24 h dosedependently. Recent studies showed that MPP + significantly decreased cell viability in a dose-dependent manner [26, 27] . While studying with SH-SY5Y cells, different concentrations suh as 500 μM, 1 mM or 2 mM MPP + were shown to decrease cell viability [27, 28] . In our study model, 2.3 mM concentration of MPP + was needed to decrease cell viability to 50% at 24h.
Previous studies reported that exposure to nM concentrations of rotenone for 24 hours was found to decrease SH-SY5Y cell viability to 50% when compared to untreated cells [29, 30] . However, rotenone at higher concentrations were needed to effect cellular viability in our study model, similar to recent studies [31, 32] . At lower concentrations, we could not observe any damage. Thus, 50 µM rotenone was used to induce cellular damage for further analysis. Consistent with previous studies, we observed significant decreases in cell viability following paraquat or 6-OHDA treatments at different time points [33] [34] [35] . It is suggested that performing dose-response studies while studying, particularly, rotenone-induced neurotoxicity is very important before investigating molecular responses of neurotoxins.
Although it is reported that neurodegenerative diseases have common mechanisms including oxidative stress, protein aggregation, mitochondrial dysfunction and apoptosis etc., the molecular mechanisms that lead to neuronal pathology are still unclear. Therefore, an effective treatment strategy for these diseases is not yet available. Following the discovery of a link between apoptosis and neurodegenerative diseases, there is a widespread interest in agents that inhibiting the apoptosis of neural cells.
Bcl-2 family proteins are divided into two groups as apoptotic and anti-apoptotic proteins that are mainly involved in the regulation of apoptosis [36, 37] . Enhanced Bax and Bad activities are very crucial for cellular fate due to the regulatory role of Bax for release of proapoptotic mitochondrial proteins into the cytoplasm. Siddiqui et al. (2013) showed that rotenone exposure significantly increased mRNA and protein levels of Bax and p53 as well as decreased mitochondrial membrane potential supporting its mitochondrialtargeted effect [38] . Similarly, it was reported that Bax levels were significantly increased when cells treated with 150 µM 6-OHDA [34] . In our study, the alterations in levels of apoptosis-related proteins were evaluated following neurotoxin treatments. As expected, rotenone and paraquat treatments significantly increased Bax and Bak protein levels in our study. Surprisingly, MPP + and 6-OHDA at selected concentrations that caused 50% cell death were failed to increase Bax protein levels (p>0.05). On the other hand, 6-OHDA was the only neurotoxin which managed to increase Bad protein levels. In the light of these findings, it can be suggested that working concentration of a neurotoxin should be carefully chosen and confirmed before further specific analysis on pro-apoptotic proteins.
Bcl-2 and Bcl-xl are anti-apoptotic proteins that inhibit apoptosis by directly binding to pro-apoptotic proteins [39] . In our study, MPP + , rotenone and paraquat treatments significantly decreased Bcl-2 and Bcl-xl protein levels, consistent with previous studies [38, 40] . All neurotoxins were found to exert similar behaviour. Thus, we observed that any neurotoxin is not superior to the other in terms of anti-apoptotic protein regulation. In addition to individual analysis of proteins, the ratio of Bax to Bcl-2 can be used as an indicator of susceptibility of a cell to apoptosis [41] . Since Bax/Bcl-2 ratio is associated with increased cell death, we examined apoptotic stimuli by increased Bax/Bcl-2 ratio following treatments in our study model. MPP + , rotenone and paraquat treatments were found to increase Bax/Bcl-2 ratio when compared to untreated cells suggesting and confirming their modulatory roles in pore formation on mitochondrial membrane.
Following activation of caspases during apoptosis, there is an increase in cleaved caspase-3 levels which is the active form of caspase-3 enzyme. Therefore, significant decrease can be observed in total caspase-3 levels. However, neurotoxins could not effect protein expression levels of caspase-3 at selected concentrations and time period of exposure in our study model. In agreement with the earlier findings by Ramachandıran et al. (2007), we did not observe any evidence of caspase-dependent apoptosis in cells during any of neurotoxins-induced toxicity. Further studies are still needed to compare the mechanisms of action of various neurotoxins that are used to induce cellular damage [21] .
CONCLUSION
Therapeutic approaches that have been shown to be effective for a variety of neurodegenerative disorders in in vitro and animal models and that target the apoptotic pathway appear to give conflicting results in human clinical trials [6, 42] . Similar to previous data obtained by Giordano et al. [43] , we did not observe similar changes in terms of apoptotic proteins following rotenone, MPP + , paraquat, 6-OHDA treatments at doses that induce cell death in SH-SY5Y cells. In the light of these findings, it can be concluded that deciding an experimental model should be one of the most important strategies before starting drug studies that target apoptosis.
MATERIALS AND METHODS
Cell culture and treatments
The human neuroblastoma cell line (SH-SY5Y) used in this study was purchased from the American Type Culture Collection (ATCC, Catalog #CRL-2266). Cells were suspended in complete Dulbecco's modified Eagle Medium (DMEM) (Life Technologies, Gibco BRL, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS, Hyclone), 1% penicillin and streptomycin (100 U/ml, Invitrogen) and plated in poly-L-lysine-coated culture dishes. The cultures were incubated in 1:4 passages at 37°C in 5% CO2 95% humidified atmosphere. For drug treatments, cells were transferred to 6-or 96-well plates or culture dish.
Parkinsonian toxin-induced toxicity
The dose-response and time-response studies for MPP + , rotenone, paraquat and 6-OHDA were performed to determine the concentration (IC50) and duration of toxicity. Cells were seeded (5X10 3 cells/well) in 96-well culture dishes and incubated for 24 hours in 5% CO2 and 37°C incubator. Various concentrations of toxins (0.5, 5, 10 mM for MPP + ; 0.1, 1, 10 µM for rotenone; 0.1, 0.5, 1 mM for paraquat; 50, 100, 500 µM for 6-OHDA) were added and incubated for 12, 24 or 48 hours. Then, 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT) cell viability test was applied. IC50 value and exposure time were calculated for each toxins.
MTT assay
Percent cell viability was assessed using the MTT assay. Following exposures, 20μL of MTT solution (5 mg/ml phosphate buffer) was added to each well and incubated for 3 hours in 5% CO2 and 37°C incubator. Then, 100 μL DMSO was added and kept in a 5% CO2 incubator at 37°C for 10 minutes to dissolve the formazan crystals. Microplate reader (Multiskan Go, Thermo Scientific) was used to measured each well at a wavelength of 570 nm.
Western blotting
BCA Protein Assay Kit (Pierce, 23225) was used for protein content determination. Western blotting was performed by loading 30 µg protein on 10% (w/v) tris-glycine denaturing gels and separating proteins by electrophoresis, then transferring to PVDF membrane. After blocking, the membrane was incubated with primary antibodies (anti-Bax, anti-Bcl-2, anti-Bcl-xl, anti-Bad, anti-Bak, anti-caspase-3; 1:1000, Cell Signaling) at +4°C overnight. After washing, the membrane was incubated with peroxidase-conjugated secondary antibodies for 1 h to visualize labeled proteins by enhanced chemiluminescence.
Statistical analysis
All data were expressed as means ± standard deviation (SD) for six independent experiments for MTT analyses and three independent experiments for protein expression analyses. Comparisons of means between groups were performed by one-way analysis of variance (ANOVA) followed by Tukey's post hoc test. p <0.05 was considered statistically significant.
